Migraine Therapeutics Market (Therapeutics - Pain-relieving Medications, and Preventive Medications; Route of Administration - Oral, Nasal, and Injectables): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

A recent report published by Infinium Global Research on migraine therapeutics market provides in-depth analysis of segments and sub-segments in the global as well as regional migraine therapeutics market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional migraine therapeutics market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global migraine therapeutics market.

Market Insight:

The global migraine therapeutics market was valued at more than USD 4.70 billion in 2022 and is expected to reach nearly USD 9.50 billion in 2030, with a CAGR of about 9% during the forecast period 2023-2030.

Migraine is a frequent disease with a point prevalence of 20% in women and 8% in men. Therefore, guidelines for the prevention of migraine attacks through pharmacological therapy or developmental therapy are very important from a practical standpoint. The purpose of this guideline is to enhance the treatment of acute migraine attacks and the prevention of migraine. In migraine, there are attacks of moderate to severe, frequently one-sided pulsating-throbbing headaches which increase in intensity on physical activity. One-third of the patients suffer holo cranial headaches. Signs of activation of the parasympathetic system are observed in up to 82% of the patients, most often with mild watering eyes. When the head pains are one-sided, they may change sides for the duration of an attack or from one attack to another. The intensity of the attacks may vary significantly from attack to attack.

Growing awareness about migraine and treatment options and rising R&D spending led to enormous pipeline products. An increase in the occurrence of migraines with high unmet needs is contributing to the overall growth of the migraine therapeutics market. Further, an increase in awareness and healthcare expenditure boosts the market growth over the forecast period. The various strategic activities by the key market players, such as product launches and product approvals, as well as mergers and acquisitions, boost the market over the upcoming period. Thus, the market is estimated to project growth over the forecast period. However, the Side effects of medication are expected to hamper the market growth. Moreover, the development of novel drugs and therapies for the treatment of migraine is expected to offer significant growth opportunities.

Based on regional analysis, the global migraine therapeutics market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is expected to dominate the overall market and is projected to maintain its dominance over the forecast years. The high occurrence of migraine, the increasing adoption of novel therapeutics, and the large target population in the United States are the factors that contribute to the region's dominance. Asia Pacific is also expected to witness robust growth in the global migraine therapeutics market due to the rise in the burden of migraine increasing adoption of novel therapeutics and the large target population in the region.

Report Scope of the Migraine Therapeutics Market:

Segment Covered

The report on global migraine therapeutics market covers segments such as therapeutics, and route of administration. On the basis of therapeutics, the sub-markets include pain-relieving medications, and preventive medications. On the basis of route of administration, the sub-markets include oral, nasal, and injectables.

Companies Profiled:

The report provides profiles of the companies in the market such as Amgen Inc., Vaxxinity, Eli Lilly and Company, Pfizer Inc. , Novartis AG, AEON Biopharma, Sosei Group Corporation, Satsuma Pharmaceuticals, Inc., Allodynic Therapeutics, and Trevena, Inc..

Report Highlights:

The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the migraine therapeutics market. Moreover, the study highlights current market trends and provides forecasts from 2023-2030. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.